Skip to main content
NIH funding notice RFA-DA-22-039

Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R21 - Clinical Trial Optional)

Closed on February 9, 2022.

Posted
September 8, 2021
Close date
February 9, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $393,125 in first-year total cost, median $196,563.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 PXN-F (01)]2

Most frequent institutions

  1. WASHINGTON STATE UNIVERSITY1
  2. YALE UNIVERSITY1
Competing awards under RFA-DA-22-039 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Pharmacokinetic and motivational properties of vaporized cannabis in mice1R21DA057245-01DELEVICH, KRISTEN MARIEHAYASHI, KANAKOMCLAUGHLIN, RYAN JOSEPHWASHINGTON STATE UNIVERSITY, WA$229,500ZDA1
2022Pharmacokinetics and Pharmacodynamics of Oral and Vaporized THC in Older Adults1R21DA057240-01DE AQUINO, JOAO PAULOYALE UNIVERSITY, CT$163,625ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.